Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Slattery

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
Blood|February 9, 2000
Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of ageH J Deeg, H M Shulman, J E Anderson, et al.
Bone Marrow Transplantation|July 1, 1995
Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokineticsJ T Slattery, J E Sanders, C D Buckner, et al.
Blood|April 15, 1997
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantationJ T Slattery, R A Clift, C D Buckner, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
Blood|February 9, 2000
Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of ageH J Deeg, H M Shulman, J E Anderson, et al.
Bone Marrow Transplantation|July 1, 1995
Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokineticsJ T Slattery, J E Sanders, C D Buckner, et al.
Blood|April 15, 1997
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantationJ T Slattery, R A Clift, C D Buckner, et al.
Pageof 12